Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, D. G.
Harkness, E. F.
Holmen, M. M.
Tharmaratnam, K. U.
Hagen, A. I.
Maxwell, A. J.
Funding for this research was provided by:
Medical Research Council (G960413)
unspecified valid from 2016-04-14